Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 105957101000001114 | Trelegy Ellipta | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 105957201000001119 | Trelegy Ellipta (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trelegy Ellipta | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) | Is a | True | Trelegy Ellipta | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR